REG - Alliance Pharma PLC - Notification of Full Year Results

Alliance PharmaAnnouncement

15/02/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220215:nRSO6444Ba&default-theme=true

RNS Number : 6444B  Alliance Pharma PLC  15 February 2022

 

 For immediate release
                        15 February 2022

 

ALLIANCE PHARMA PLC

("Alliance" or the "Group")

 

Notification of Full Year Results,

Analyst Meeting and Webcast

 

Alliance Pharma plc (AIM: APH), the international healthcare group, will
announce its results for the year ended 31 December 2021 on Tuesday 22 March
2022.

A meeting for analysts will be held at 9.30am on the day of the results at
Investec Bank plc, 30 Gresham Street, London EC2V 7QP. To register for the
meeting, analysts should contact Buchanan at alliancepharma@buchanan.uk.com
(mailto:alliancepharma@buchanan.uk.com) .

A live webcast of the analyst meeting will be accessible via the following
link: https://webcasting.buchanan.uk.com/broadcast/620a757b26d01a4c0553d15f
(https://webcasting.buchanan.uk.com/broadcast/620a757b26d01a4c0553d15f) .

A recording of the webcast will be made available following the meeting at the
investor section of Alliance's website,
https://www.alliancepharmaceuticals.com/investors
(https://www.alliancepharmaceuticals.com/investors) .

 

For further information:

 

 Alliance Pharma plc                                     + 44 (0)1249 466966
 Head of Investor Relations: Cora McCallum
 ir@allianceph.comwww.alliancepharma.co.uk

 Buchanan                                                + 44 (0)20 7466 5000
 Mark Court / Sophie Wills / Hannah Ratcliff
 alliancepharma@buchanan.uk.com

 Numis Securities Limited                                + 44 (0)20 7260 1000
 Nominated Adviser: Freddie Barnfield / Duncan Monteith
 Corporate Broking: James Black

 

 Investec Bank plc                + 44 (0) 20 7597 5970
 Corporate Finance: Daniel Adams
 Corporate Broking: Patrick Robb

 

About Alliance

Alliance Pharma plc (AIM: APH) is an international healthcare group. Our
purpose is to improve the lives of consumers and patients through making
available a range of clinically valuable healthcare products.

Our core focus is on the marketing of Consumer Healthcare brands, complemented
by a smaller Prescription Medicines business. In total, we hold marketing
rights to around 80 brands, with revenues generated from a mix of direct,
distributor and e-commerce sales.

Headquartered in the UK, the Group employs around 250 people based in
locations across Europe, North America, and the Asia Pacific region. By
outsourcing our manufacturing and logistics operations, we remain asset-light
and focused on maximising the value of our brands.

For more information on Alliance, please visit our website:
www.alliancepharmaceuticals.com (http://www.alliancepharmaceuticals.com)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORSFIFWLEESESE